Investorideas.com newswire, breaking stock news, business news and commentary for marijuana sector

Tuesday, August 22, 2017

Quadron Cannatech (CSE:QCC) (CSE:QCC.CN) (CNSX:QCC) Receives Two Software and Automation Control Panel Contracts from Major US Entertainment Theme Park

Quadron Cannatech (CSE:QCC) (CSE:QCC.CN) (CNSX:QCC) Receives Two Software and Automation Control Panel Contracts from Major US Entertainment Theme Park

VANCOUVER, BRITISH COLUMBIA - August 22, 2017 (Investorideas.com Newswire) Quadron Cannatech Corporation (the "Company" or "Quadron") (CSE:QCC)(CSE:QCC.CN)(CNSX:QCC) is pleased to announce that its wholly owned subsidiary, Cybernetic Controls Systems ("Cybernetic"), has secured two software automation and control panel contracts for two rides for a major US entertainment theme park operator.

The US entertainment theme park chose Cybernetic for its expertise, ingenuity and most importantly, flexibility due to the changing requirements and specifications of the contracts requirements.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Maricann Group (CSE:MARI) (CSE:MARI.CN) (CNSX:MARI) Announces Acquisition of NanoLeaf Technologies Inc., Appoints New President and Chief Operating Officer

Maricann Group (CSE:MARI) (CSE:MARI.CN) (CNSX:MARI) Announces Acquisition of NanoLeaf Technologies Inc., Appoints New President and Chief Operating Officer

TORONTO, ONTARIO - August 22, 2017 (Investorideas.com Newswire) Maricann Group Inc. (CSE:MARI) (CSE:MARI.CN) (CNSX:MARI) ("Maricann" or the "Company") announced today that it has entered into an agreement ("Acquisition Agreement") to acquire 100% of the issued and outstanding shares of NanoLeaf Technologies Inc. ("NanoLeaf"), a biotech company possessing licensing rights to a number of globally patented technologies that provide proven pharmaceutical, nutraceutical, cosmetic and functional beverage drug delivery formulations. The transaction is expected to be completed by the end of September 2017.

NanoLeaf, through its licensing agreement with Vesifact, has developed and marketed the first cannabinoid standardized dose soft gel capsule in a nano-dispersed drug called Vesisorb. The challenge the cannabis industry has faced is finding a predictable delivery mechanism of cannabinoids in an oral dosing format. Cannabinoids are a fat-soluble compound that have low solubility, leading to low dissolution rates and significant first-pass liver metabolism resulting in low and unpredictable oral cannabinoid bioavailability. This poor solubility not only gives low oral bio-availability but also leads to high inter- and intra-subject variability and lack of dose proportionality.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Hydropothecary (TSX VENTURE: $THCX.V) Enters into Agreement to Build a 250,000 sq. ft. Expanded Production Facility

Hydropothecary (TSX VENTURE: $THCX.V) Enters into Agreement to Build a 250,000 sq. ft. Expanded Production Facility

GATINEAU, QC - August 22, 2017 (Investorideas.com Newswire) The Hydropothecary Corporation (TSX VENTURE: THCX) (the "Company" or "Hydropothecary") is pleased to announce that it has entered into an agreement with Havecon Projects BV ("Havecon") for the delivery and installation of a 250,000 sq. ft. Dutch designed, state-of-the-art Venlo style greenhouse at the Company's 65 acre Gatineau facility, with construction expected to begin in the fall of 2017. This agreement will allow Hydropothecary to leverage Havecon's years of experience in delivering the highest quality products and supporting world-class growing operations, while meeting the Company's ambitious timeline.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


SinglePoint (OTC: $SING) Continues Accelerated Growth in Cannabis Sector with Letter of Intent to Acquire Dr. FeelGood

SinglePoint (OTC: $SING) Continues Accelerated Growth in Cannabis Sector with Letter of Intent to Acquire Dr. FeelGood



SEATTLE, WA - August 22, 2017 (Investorideas.com Newswire) SinglePoint, Inc. (OTC:SING) today announces it has signed a Letter of Intent (LOI) to acquire Dr. FeelGood, an already profitable Phoenix-based medical marijuana distribution company with plans to develop a proprietary delivery and ordering technology. Per the LOI, SinglePoint will acquire 51% of the company in a combination of cash and stock. The acquisition will add an additional revenue stream to SinglePoint, solidifying the company's acquisition-based revenue strategy.

SinglePoint anticipates it will quickly close this acquisition, demonstrating its ability to grow its portfolio of investments in established high-growth, high-potential cannabis businesses. SinglePoint successfully acquired two companies earlier this year, and expects that the acquisition of Dr. FeelGood will be a highly successfully addition to its portfolio.

Read this news in full at

About the Company
SinglePoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed the company is providing products and services to the cannabis industry.




Disclosure: SinglePoint, Inc. (OTC: $SING) is featured on the 420 Cannabis Investor Ideas of 2017 at www.420cannabisinvestorideas.com

SinglePoint, Inc. (OTC: SING) is a featured company on Investorideas.com
View the profile on Investorideas.com

Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory and SING is also a paid featured cannabis and bitcoin company for news and PR social media
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Monday, August 21, 2017

Medical Cannabis Innovator Set to Go Public

Medical Cannabis Innovator Set to Go Public


August 21, 2017 (Investorideas.com Newswire) A licensed producer of medical cannabis in Canada will begin trading on the Canadian Securities Exchange on Aug. 21.





Shares of CannTrust Holdings Inc. (TRST:CSE), which has a 40,000 square foot hydroponic production facility in Vaughan, Ontario, will begin trading on the Canadian Securities Exchange on Monday, Aug. 21 under the symbol TRST.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video

 

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

V2 Launches Prohibited Cannabis Vaporizer Brand and Product Line

V2 Launches Prohibited Cannabis Vaporizer Brand and Product Line

First Device in Product Line, 5th Degree, Now Available Online and in Select Retail Locations

NEW YORK - August 21, 2017 (Investorideas.com Newswire) Prohibited - the all new cannabis vape brand by leading independent e-cig and manufacturer, V2 - today, announced the launch of the 5th Degree vaporizer, now available for customers nationwide online and on shelves in 125 retailers in 18 states across the country. The 5th Degree is a 3-in-1 device designed and optimized for marijuana consumption.

The 5th Degree features variable voltage and temperature settings, a powerful battery and pass-thru charging. The vaporizer also comes with two magnetic drop-in cartridges; one for buds and one for concentrates or e-liquid. 5thDegree will automatically recognize each type of cartridge and perform accordingly.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


#Cannabis Stock News: iAnthus (CSE: IAN) (OTCQB: $ITHUF) Announces Update to Proposed Acquisition of Citiva

#Cannabis Stock News: iAnthus (CSE: IAN) (OTCQB: $ITHUF) Announces Update to Proposed Acquisition of Citiva

NEW YORK, NY and TORONTO, ON - August 21, 2017 (Investorideas.com Newswire) iAnthus Capital Holdings, Inc. ("iAnthus" or "the Company"), (CSE: IAN) (OTCQB: ITHUF), which owns, operates, and partners with licensed cannabis operations throughout the United States, announces that it has advanced US$500,000 to Citiva Medical, LLC ("Citiva NY") pursuant to a secured promissory note (the "Promissory Note"). The Promissory Note has a term of one year, subject to acceleration in certain events, and yields interest at a rate of up to 20%.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 





This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.